Pharmalot... Pharmalittle... Good Morning

Rise and shine, everyone, the middle of the week is here. If you can make it through today, the rest should be downhill, yes? Well, we are among the optimists, after all. Meanwhile, there is much to do, as always. So, no time to waste. Please join us as we reach for that needed cup of stimulation and brace for another round of phone calls, meetings and document reading. We trust you can relate. To help you along, yes, we have some tidbits. Have a grand day and do keep us in mind when something fascinating pops up... Regeneron Drug Lowers Cholesterol In Late-Stage Trial (Reuters) Glaxo Exec Assists China In Bribery Probe, Barred From Leaving (The Guardian) Eisai And Arena Double Sales Force For Diet Drug (MarketWatch) J&J Faces Off Against Topamax Users Over Birth Defects (Bloomberg News) FDA Approves Novo Nordisk Hemophilia A Drug (Pharma Times) Reglan Nausea Drug Is Safe During Pregnancy: Study (MedPage Today) J&J Withdraws Appeal In DePuy Case In India (Economic Times) EDITOR'S NOTE: Please check this post for additional stories during the day Read more
Source: Pharmalot - Category: Pharma Commentators Authors: Source Type: blogs